Advertisement

Topics

ABAC Therapeutics Announces €16M Series A to Develop Therapeutic Solutions to Fight Antibiotic-Re...

19:00 EST 14 Feb 2018 | BioSpace

The financing was led by Pontifax with participation from the Global Health Science Fund.

Original Article: ABAC Therapeutics Announces €16M Series A to Develop Therapeutic Solutions to Fight Antibiotic-Re...

NEXT ARTICLE

More From BioPortfolio on "ABAC Therapeutics Announces €16M Series A to Develop Therapeutic Solutions to Fight Antibiotic-Re..."

Advertisement
Quick Search
Advertisement
Advertisement